Comment on: Zhu et al. Fasting Plasma Glucose at 24–28 Weeks to Screen for Gestational Diabetes Mellitus: New Evidence From China. Diabetes Care 2013;36:2038–2040
Authors:
- Charles Savona-VenturaCSCharles Savona-Ventura
- Michel MarreMMMichel Marre
- for the MGSD-GDM Study GroupFGfor the MGSD-GDM Study Group
Open Access
- 13 August 2013
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 36 (9) , e165
Abstract
The article by Zhu et al. (1) published in Diabetes Care concludes that a fasting plasma glucose (FPG) at 24–28 weeks’ gestation can be used in low-resource regions as a screening test to identify gestational diabetes mellitus (GDM) in Chinese patients. However, in their experience, a screening protocol using FPG cutoff points of ≥4.4 and ≤5.0 mmol/L would fail to identify about 12% of the GDM cases and require a formal oral glucose tolerance test (OGTT) to be performed in about half of the pregnant population (1). These observations contrast with our findings in a circum-Mediterranean population (2). In our …Keywords
This publication has 2 references indexed in Scilit:
- Fasting Plasma Glucose at 24–28 Weeks to Screen for Gestational Diabetes MellitusDiabetes Care, 2013
- A composite risk assessment model to screen for gestational diabetes mellitus among Mediterranean womenInternational Journal of Gynecology & Obstetrics, 2012